Senores Pharmaceuticals Ltd. IPO

Senores Pharmaceuticals IPO is a book-built issue worth Rs 582.11 crores, comprising a fresh issue of 1.28 crore shares aggregating to Rs 500.00 crores and an offer for sale of 0.21 crore shares worth Rs 82.11 crores. The IPO opens for subscription on December 20, 2024, and closes on December 24, 2024. Allotment is expected on December 26, 2024, with a tentative listing date of December 30, 2024, on BSE and NSE. The price band is Rs 372 to Rs 391 per share. Retail investors can apply for a minimum lot size of 38 shares, requiring Rs 14,858. sNII and bNII investments start at Rs 2,08,012 and Rs 10,10,344, respectively.

RHP
View
DRHP
View
Open Date

2024-12-20

Close Date

2024-12-24

Senores Pharmaceuticals Ltd. IPO Details

Check out the issue details for Senores Pharmaceuticals Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 391

Price Band

₹ 372 - 391

Issue Size

582.11 Cr.

Issue Type

Book Built

Open

2024-12-20

Close

2024-12-24

Listingprice

₹ 600

ListingGain

53.45%

Listing Date

2024-12-30

CMP

₹ 496.1

Current Return

26.88%

Senores Pharmaceuticals Ltd. News

Senores Pharmaceutic - Quaterly Results15 May, 7:08PM Senores Pharmaceuticals informs about media release9 May, 12:51PM Senores Pharmaceuticals informs about media release9 May, 9:58AM Senores Pharmaceuticals inks agreement to acquire ANDA for Tramadol Tablets9 May, 9:22AM Senores Pharmaceuticals inks agreement to acquire ANDA for Topiramate HCl 25, 50, 100, 200 mg tablets5 May, 6:02PM Senores Pharmaceuticals informs about updates22 Apr, 5:01PM Senores Pharmaceuticals informs about change in contact details of RTA19 Apr, 4:24PM Senores Pharmaceuticals informs about certificate3 Apr, 5:24PM Senores Pharmaceuticals to acquire 3.73% paid up share capital of Havix12 Mar, 12:23PM Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s Laboratories 4 Mar, 3:58PM Senores Pharmaceuticals starts operations at greenfield API facility in Gujarat 27 Feb, 9:44AM Senores Pharmaceuticals inks pact to acquire ANDA for Roflumilast 250 mcg, 500 mcg tablets 21 Feb, 10:38AM Senores Pharmaceuticals informs about press release24 Jan, 3:25PM Senores Pharmaceuticals informs about media release23 Jan, 5:25PM Senores Pharmaceutic - Quaterly Results23 Jan, 1:55PM Senores Pharmaceutic - Quaterly Results23 Jan, 1:55PM Senores Pharmaceutic - Quaterly Results23 Jan, 1:55PM Senores gets USFDA’s final nod for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet10 Jan, 9:22AM Senores Pharmaceuticals coming with IPO to raise upto Rs 608 crore19 Dec, 4:08PM Senores Pharmaceuticals gets Sebi's nod to float IPO 16 Oct, 12:22PM

Company Financials

You can get the following financial statements of Senores Pharmaceuticals Ltd. as of now.

Exchange

NSE: SENORES BSE: 544319

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Senores Pharma IPO Details

The details about the Senores Pharma IPO are as follows:

  • The issue size of the IPO is 582.11 Cr.
  • The price band for Senores Pharma IPO is Rs 372 to Rs 391.
  • The shares of Senores Pharma IPO will list on 30th December 2024.
  • The latest tentative GMP of Senores Pharma IPO is Rs 230.
  • The shares of Senores Pharma IPO are subscribed 97.86 Times.

 

Senores Pharma IPO Valuation

The approx valuation of Senores Pharma IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 391
Existing Shares (Qty) 3.32 Cr
Fresh Issue 500 Cr
Market Cap 1798.12 Cr
EPS (FY24) Rs 13.67
PE Ratio 28.60x
Industry PE 38.84x

 

Senores Pharma IPO Issue Size

Senores Pharma IPO issue size is 582.11 Cr.

Issue Amount
Fresh Issue 500 Cr
Offer For Sale 82.11 Cr

 

Senores Pharma IPO Market Lot

An individual can apply for a minimum of 1 lot of 38 shares and a maximum of 13 lots of 494 shares. Find the details below:

Application Lot Shares Amount
Minimum 1 38 Rs 14,858
Maximum 13 494 Rs 1,93,154

 

Senores Pharma IPO Share Offer

The shares of Senores Pharma IPO are subscribed 97.86 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Minimum 75%
Non-Institutional Maximum 15%
Retail Individual Maximum 10%

 

Senores Pharma IPO GMP (Grey Market Premium)

As on GMP (Tentative)
24 December 2024 Rs 230

Senores Pharma IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Senores Pharma IPO Dates

Find below the dates for Senores Pharma IPO

Schedule Date
Basis of Allotment 26 December 2024
Refunds 27 December 2024
Credit to Demat Account 27 December 2024
IPO Listing Date 30 December 2024

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Net Sales 13.54 12.38 34.01
Total Expenditure 12.39 14.16 34.07
Operating Profit 1.16 -1.78 -0.06
Other Income 0.94 6.79 6.85
Interest 0.56 2.14 2.71
Depreciation 0.71 0.93 2.04
Exceptional Items 0 0 0
Profit Before Tax 0.83 1.94 2.04
Provision for Tax 0.15 0.74 1.22
Net Profit 0.68 1.2 0.81
Adjusted EPS (Rs.) 0.08 0.12 0.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.74 9.82 30.51
Total Reserves 24.95 29.11 137.61
Borrowings 12.22 24.17 19.88
Other N/C liabilities 0.01 1.66 7.02
Current liabilities 8.8 46.79 90.65
Total Liabilities 54.72 111.54 285.65
Assets
Net Block 1.59 7.77 24.09
Capital WIP 0 8.06 14.88
Intangible WIP 3.17 3.27 3.59
Investments 11.69 8.23 81.58
Loans & Advances 24.14 56.13 102.08
Other N/C Assets 0.14 0.4 19.48
Current Assets 13.98 27.68 39.96
Total Assets 54.72 111.54 285.65
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025
Other Income 7.19 9.25
Profit Before Tax 1.32 2.9
Tax 0.25 0.89
Profit After Tax 1.07 2.01
Adjusted EPS (Rs) 0.23 0.44

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 45.77 0
Dec 2024 45.76 0
Sep 2024 45.76 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.83 1.94 2.04
Adjustment 0.6 -1.57 -2.59
Changes in Assets & Liabilities -25.35 -43.32 -61.07
Tax Paid -0.14 -0.47 -1.19
Operating Cash Flow -24.06 -43.41 -62.82
Investing Cash Flow -10.05 -5.23 -13.51
Financing Cash Flow 33.88 47.08 86.68
Net Cash Flow -0.23 -1.57 10.35
X